Fuda Cancer Hospital - Philippines

Fuda Cancer Hospital - Philippines Fuda is committed to providing cancer patients around the world with the best medical care.

Fuda Cancer Hospital is considered one of the BEST cancer hospitals in China by patients and is affiliated to Jinan University and Translational Medicine Center Fuda Cancer Hospital South District and Fuda Cancer Hospital North District (collectively, “Fuda Cancer Hospital”) are located in Guangzhou, in the south of China. Both hospitals are modern and specialized cancer centers that are recognize

d for their minimally invasive therapies and innovative treatments that provide an effective alternative to the traditional treatment of chemotherapy/radiation/surgery. Fuda Cancer Hospital is affiliated with the Chinese Academy of Sciences’ Guangzhou Institute of Biomedicine and Health. The hospitals are teaching hospitals of Jinan University School of Medicine. In 2010, the central government designated the hospitals as nationally important clinics and awarded a five million RMB grant to them. The honorary president of the hospital is Academician Mengchao Wu, and the president is Professor Kecheng Xu, a renowned and highly respected specialist of general oncology and gastroenterology. Fuda Cancer Hospital focuses on the diagnosis and treatment of liver, lung, breast, nasopharyngeal, colorectal, uterus, stomach, esophageal, pancreatic, tongue, prostate, skin, larynx, and lymphoma cancers, as well as many others. The hospital insists on providing patient care and services and adopting an individualized approach in the treatment of patients based on their individual conditions. By combining conventional treatment with newly developed technologies and traditional Chinese medicine, the hospital is equipped to treat patients with a complete spectrum of available therapies, from the traditional to the cutting-edge. Besides the conventional treatments for cancer (surgery, chemotherapy and radiotherapy) the hospital has brought together innovative and proven new technologies such as Nano Knife Therapy, Interventional Hepasphere, cryosurgical ablation (CSA), vascular interventional therapy, Cancer Microvessel Intervention (CMI), photodynamic therapy, seed knife brachytherapy, radiofrequency ablation and bioimmunotherapy. The hospital prides itself on using a “3C+P” approach when treating patients: CSA, CMI, combined immunotherapy for cancer (CIC), and personalized therapy. So far, Fuda Cancer Hospital has performed more than 10,000 cases of cryosurgical ablation, and it performs the most number of cryosurgical ablations annually in the world. Dr. Franco Lugnani, the president of the International Society of Cryosurgery, has lauded Fuda for its efforts. Furthermore, the International Society of Cryosurgery designated the hospital as a training center for doctors from the Asian-Pacific region who are interested in cryosurgery. The hospital’s concept and diagnostic techniques have gained a great reputation from countries throughout southeast Asia, as well as the United States, the United Kingdom, Spain, Denmark, Netherlands, and other countries.

[Fuda News | World Ablative Therapies Association (WATA 2026)]Global Ablation Experts Gather as FudaShines at WATA 2026F...
21/05/2026

[Fuda News | World Ablative Therapies Association (WATA 2026)]

Global Ablation Experts Gather as FudaShines at WATA 2026
From May 15 to 17, 2026, the inaugural academic conference of the World Ablative Therapies Association (WATA 2026) was held in Beijing, China.

As WATA’s first global academic event, the conference was themed “United in Ablation Worldwide: Building Consensus, Advancing Evidence, Pursuing Excellence.” Leading experts and scholars from more than 30 countries and regions gathered to discuss clinical topics, technological innovation, and discipline development in tumor ablation, while exploring the latest advancements and future directions of ablation therapy.
On May 15, the pre-conference international training courses officially kicked off, focusing on key topics including lung tumor ablation, thyroid tumor ablation, irreversible electroporation (NanoKnife), and liver tumor ablation. Guangzhou Fuda Cancer Hospital President Niu Lizhi was invited to attend and delivered two keynote presentations: Standardization and Techniques of Cryoablation for Liver Cancer and Clinical Application of NanoKnife for Liver and Pancreatic Tumors Under Combined Ultrasound and CT Guidance.

During the training sessions, President Niu shared extensive clinical experience through numerous classic cases, explaining both the technical essentials and clinical challenges of various ablation procedures in a clear and practical manner. Particularly noteworthy was the internationally pioneered “two-needle technique” for NanoKnife ablation developed by Fuda, which received high praise from attending experts and scholars for its cost-effectiveness, safety, and efficiency.
At the Breast and Gynecologic Ablation Session, Ma Yangyang delivered a special presentation titled Cryoablation for Breast Cancer. He noted that compared with traditional open surgery, cryoablation offers several advantages, including minimal trauma, faster recovery, repeatability, real-time imaging guidance, and better cosmetic preservation of the breast.
For carefully selected patients with early-stage breast cancer, as well as those with recurrent or metastatic disease or patients unable to tolerate surgery, cryoablation can serve as an important complementary approach for local tumor control and multidisciplinary treatment.

Importantly, cryoablation is not only a local treatment modality but may also activate anti-tumor immune responses through mechanisms such as tumor antigen release, immunogenic cell death, and modulation of the tumor microenvironment. As a result, the combination of cryoablation with systemic therapies — including immunotherapy, targeted therapy, endocrine therapy, and chemotherapy — is emerging as a promising direction in comprehensive breast cancer treatment. In his presentation, Director Ma also highlighted the value of cryoablation in local tumor control, symptom relief, synergistic multidisciplinary treatment, and potential immune activation based on recent research findings and clinical experience.

As a global academic organization initiated by Chinese physicians, WATA 2026 brought together leading ablation experts from around the world in Beijing, creating a high-level international platform for academic exchange and collaboration. Experts shared their practical experience and unique insights, and the cross-border exchange of ideas greatly benefited all participants.
Notably, the conference also officially designated May 16 as “World Ablation Day” for the first time, marking a new milestone in the global development of ablation therapy in the fight against cancer.
Guangzhou Fuda Cancer Hospital has long been dedicated to the field of minimally invasive cancer therapy. By actively participating in this international conference and sharing China’s experience in tumor ablation, the hospital once again demonstrated its professional expertise and commitment in the field of ablation therapy.
Taking this conference and the newly established “World Ablation Day” as a new starting point, the hospital will continue to strengthen international collaboration, integrate global expertise, and work together with peers worldwide to promote the future development of minimally invasive ablation therapy toward greater precision, standardization, and innovation.

Click to learn more patient stories:
>>> https://en.fudahospital.com/

You can contact us through the following channels:
☎️ TEL: +63 917 775 3426.
🌟 WhatsApp: +63 917 775 3426.
🌍 Website: https://en.fudahospital.com/

21/05/2026

May.21.2026.
.
[Patient Story] [Malaysian-Smarca4 – Interventional Chemotheray]
>>>Given Just 3 Months to Live: Malaysian Woman with Rare Lung Cancer Defies the Odds> https://en.fudahospital.com/

You can contact us through the following channels:
☎️ TEL: +63 917 775 3426.
🌟 WhatsApp: +63 917 775 3426.
🌍 Website: https://en.fudahospital.com/

MAY.15.2026. . [Fuda News | 2nd Annual Scientific Conference of the Egyptian Society for Treatment by Interventional Ra...
15/05/2026

MAY.15.2026.
.
[Fuda News | 2nd Annual Scientific Conference of the Egyptian Society for Treatment by Interventional Radiology (ESTIR)]

President Niu Lizhi Speaks at ESTIR, Showcasing Chinese Healthcare Along the Belt and Road
From May 10 to 11, the 2nd Annual Scientific Conference of the Egyptian Society for Treatment by Interventional Radiology (ESTIR) was successfully held in Cairo, the capital of Egypt. Leading experts from various medical fields gathered to exchange cutting-edge research findings and promote the advancement of clinical practice.

Niu Lizhi, President of Guangzhou Fuda Cancer Hospital, was invited to attend the conference and delivered two keynote presentations on “Cryoablation for Lung Cancer” and “Clinical Applications and Advances in Cryoablation.”

Drawing on extensive clinical experience and detailed data, President Niu systematically explained the significant advantages of cryoablation in the treatment of lung cancer and shared practical solutions to common challenges encountered during procedures. He noted that cryoablation offers multiple benefits, including minimal trauma, reduced bleeding, shorter treatment duration, and faster recovery. In addition, the technique can stimulate systemic immune responses and is applicable to nearly all types of solid tumors, demonstrating broad clinical potential.

Notably, just one month earlier, President Niu had also been invited to speak at Egypt’s National Liver Cancer Conference, where he delivered a presentation titled “Cryoablation for Liver Cancer,” which was highly praised by Egyptian medical professionals.

His invitation to once again participate in a major interventional medicine conference in Egypt highlights China’s growing international influence in the field of tumor cryoablation. Today, an increasing number of countries are introducing and promoting this technology, and China has undoubtedly become one of the global leaders in this field. Chinese medical technologies and equipment are now emerging as a shining symbol of China’s contribution to the Belt and Road Initiative.

Click to learn more patient stories:
>>> https://en.fudahospital.com/

You can contact us through the following channels:
☎️ TEL: +63 917 775 3426.
🌟 WhatsApp: +63 917 775 3426.
🌍 Website: https://en.fudahospital.com/

May.11.2026. . 【Fuda News | Academic Exchange】Guangdong–Hong Kong Expert Exchange on Lung Cancer Cryoablation Successfu...
11/05/2026

May.11.2026.
.
【Fuda News | Academic Exchange】

Guangdong–Hong Kong Expert Exchange on Lung Cancer Cryoablation Successfully Held in Fuda
On April 28, 2026, the Guangdong–Hong Kong Expert Exchange on Lung Cancer Cryoablation was successfully held at Guangzhou FudaCancer Hospital. Experts and scholars from institutions including Prince of Wales Hospital Hong Kong, Princess Margaret Hospital Hong Kong, Guangdong Second Provincial General Hospital, Guangdong Provincial People’s Hospital, and The First Affiliated Hospital of Guangzhou Medical University attended the event.
01CE25E2-2C26-4C2D-84F4-2C518CFD5AC1.jpg
In the morning, the Hong Kong expert delegation arrived at the hospital and conducted on-site observation and academic exchanges in the treatment center. By observing cryoablation procedures for tumors in the liver, lungs, kidneys, and adrenal glands, the experts gained a close-up understanding of the clinical applications of this technology at our hospital and across mainland China. During the session, both sides engaged in in-depth discussions on key topics such as procedural techniques, standardized workflows, and complication prevention and management, laying a solid practical foundation for further academic collaboration. The Hong Kong experts were highly impressed by the hospital’s efficiency and extensive clinical experience, remarking, “Completing seven procedures in one morning is truly impressive — both highly efficient and rich in experience.”
051AA708-A1F3-4AD0-B964-6A04A4BA615C.png
5C84B766-B844-49F9-9A09-2D8AD235C8E0.png
61721D73-22C8-4965-B6BF-C00346F83504.png
B14DFF24-F54C-42C0-92EB-92CC34781883.png
△Academic Session Opens with Expert Insights

In the afternoon, the academic lecture session officially began. At the opening ceremony, Chairman Zhao Jun extended a warm welcome to all attending experts and briefly introduced the hospital’s development achievements. He noted that Guangzhou Fuda Cancer Hospital is a National Clinical Key Specialty Hospital (Oncology) and a national-level “Little Giant” enterprise specializing in innovation and advanced technologies. Over the past two decades, the hospital has provided high-quality medical services to patients from more than 120 countries and regions worldwide.63BADEE1-510B-4CEF-8C1A-61A1EC501843.png
Chairman Zhao emphasized that under the leadership of President Niu Lizhi, the hospital’s cryoablation technology has gained wide recognition from both domestic and international peers as well as patients. The hospital has also established a dedicated Lung Nodule Diagnosis and Treatment Center, accumulating extensive clinical experience in the management of lung cancer and pulmonary nodules. He expressed hope that this exchange would spark meaningful academic dialogue and further advance cryoablation technology and cancer prevention and treatment efforts.
1A17FAFD-8E0A-4887-9A56-A6E5885B326F.jpg
In his speech, President Niu Lizhi stressed that medicine requires lifelong learning and continuous academic exchange. He noted that only through diverse perspectives and intellectual discussion can medical technologies continue to improve. He stated that the visit of the Hong Kong expert delegation reflected the medical community’s recognition of the hospital’s clinical work. He also expressed hope that both sides would deepen academic cooperation, exchange clinical experience and treatment strategies, and work together to improve cancer care and provide better medical services for patients.
7047C46E-A128-4F2D-A39D-80B5775A711F.png
8C855697-66FD-41A1-A9AC-22ED1D6E86A8.jpg
C0FE1A79-DBA6-4520-8EAC-9AD49B450D48.jpgDrawing on extensive clinical cases and detailed data, President Niu systematically explained the significant advantages of cryoablation in the treatment of lung cancer and pulmonary nodules. He also proposed practical solutions to common technical challenges encountered during procedures. According to President Niu, cryoablation may additionally stimulate systemic immune responses, and when combined with immunotherapy, could potentially achieve even better clinical outcomes.

Professor Chen Yanwei from the Department of Pulmonary and Critical Care Medicine at The First Affiliated Hospital of Guangzhou Medical University shared several representative cases involving elderly patients, patients with underlying diseases such as atrial fibrillation, as well as small or anatomically challenging pulmonary nodules. His presentation demonstrated the advantages of cryoablation, including excellent visualization, absence of thermal damage, and good patient tolerance. For lesions located in particularly difficult areas such as near the ventricles or mediastinum, the use of percutaneous robotic-assisted puncture significantly reduced procedural difficulty and enhanced treatment safety.
31DF9246-97CB-4844-BAB9-75C94AB26110.jpg
EA7A4BB5-77C3-45A2-9B19-0E7024A2E02F.png
△In-Depth Case Discussions Promote Consensus

During the case discussion session, experts from both sides conducted in-depth exchanges on several representative cases presented by the Hong Kong delegation. Topics included the feasibility of ablation, selection of ablation methods, and optimal needle placement strategies. The discussions were lively and highly interactive, with many valuable consensus points reached through professional dialogue.
This Guangdong–Hong Kong expert exchange not only deepened mutual understanding between specialists from both regions in the field of lung cancer cryoablation, but also effectively promoted experience sharing and collaborative development. More importantly, it laid a solid foundation for enhancing cancer diagnosis and treatment capabilities together and ultimately benefiting more patients.
00CD0814-A53B-4802-A4B0-5B1E354F3D9F.jpg

Click to learn more patient stories:
>>> https://en.fudahospital.com/

You can contact us through the following channels:
☎️ TEL: +63 917 775 3426.
🌟 WhatsApp: +63 917 775 3426.
🌍 Website: https://en.fudahospital.com/

07/05/2026

MAY.7.2026.
.
[Minimally Invasive Treatment] [pancreatic cancer – Nanoknife]
>>>‘Sculpting Ablation’: Nanoknife Ablation For Pancreatic Cancer> https://en.fudahospital.com/

You can contact us through the following channels:
☎️ TEL: +63 917 775 3426.
🌟 WhatsApp: +63 917 775 3426.
🌍 Website: https://en.fudahospital.com/

30/04/2026

APR.30.2026.
.
[Minimally Invasive Treatment] [Liver Metastases – Cryoablation]
>>>Patient with Sigmoid Colon Cancer: Cryoablation of Liver Metastases> https://en.fudahospital.com/

You can contact us through the following channels:
☎️ TEL: +63 917 775 3426.
🌟 WhatsApp: +63 917 775 3426.
🌍 Website: https://en.fudahospital.com/

Apr.23.2026. . [Fuda News] [Thailand – Hospital Visit]Friends from Afar! Thai Medical Experts Visit Fuda for Exchange a...
23/04/2026

Apr.23.2026.
.
[Fuda News] [Thailand – Hospital Visit]
Friends from Afar! Thai Medical Experts Visit Fuda for Exchange and Collaboration

On April 21, a delegation of medical experts from several renowned healthcare institutions in Thailand visited Guangzhou Fuda Cancer Hospital for an exchange visit. President Niu Lizhi, General Manager Jiang Fang, and Vice President Long Xin’an warmly received their Thai counterparts. Both sides engaged in in-depth discussions on cooperation and interaction in the medical field, aiming to enhance mutual understanding, promote the sharing of academic and clinical experience, and work together to improve medical services and bring more hope to patients.

1083E3CF-FB3A-4651-ABBE-36A145D04C5A.png

06D15718-566A-4150-99F1-C80AE2D6989F.jpg

During the visit, the delegation toured the hospital environment and modern facilities, gaining insight into Fuda’s history, culture, and specialty development. They focused particularly on minimally invasive cancer therapies and observed, up close, procedures such as lung tumor cryoablation and vascular interventional treatments. Detailed explanations were provided on the underlying mechanisms, intraoperative procedures, and key considerations. The Thai experts expressed high appreciation for Fuda’s technical maturity and standardized practices in the field of minimally invasive treatment.

6C177F88-0650-4719-BCC1-D886C70A9A2E.jpg

960B7213-21B0-47BB-AA62-E58D5D9AFCDE.jpg

△President Niu Lizhi and Director Liu Shupeng also offered on-site explanations, vividly introducing key technical aspects and clinical applications of ablation therapy.

Following the tour, both sides held a symposium. General Manager Jiang Fang extended a warm welcome to the Thai delegation on behalf of the hospital. She noted that China and Thailand each possess unique cultural heritages and medical traditions—such as Traditional Chinese Medicine and Thai medicine—which create broad opportunities for deeper cooperation in healthcare.

4A8E4DA4-6E77-444F-AB64-BDA8EA5BF7CA.png

Jiang introduced that over 20 years ago, Fuda took the lead in introducing cryoablation technology and successfully applied it in tumor treatment, achieving internationally advanced levels in both clinical practice and academic research, and earning wide recognition. Meanwhile, the hospital continues to uphold innovation while preserving core principles, actively adopting advanced technologies such as NanoKnife ablation, seed implantation, photodynamic therapy, and vascular interventional treatments to continuously strengthen its medical capabilities.

Fuda has also established partnerships with medical institutions across multiple countries and regions, providing systematic pre-hospital, in-hospital, and post-hospital services. In particular, it emphasizes post-treatment rehabilitation management to ensure patients’ survival outcomes and quality of life.

Jiang expressed her hope that through China–Thailand cooperation, high-quality and accessible treatment services can be provided to cancer patients worldwide. She also hopes that every Thai patient, as well as their families and friends visiting China and Fuda, can have a warm and memorable experience.

Vice President Long Xin’an shared clinical experiences involving several Thai cancer patients. Many of these patients have achieved survival of more than 10 years after systematic anti-tumor treatments. He noted that most Thai patients who come for treatment are already in advanced stages and may not benefit significantly from conventional surgery, radiotherapy, or chemotherapy. However, at Fuda, a multidisciplinary team approach—combining local ablation with systemic therapy—often yields significantly better outcomes than single-modality treatments.

4F468433-8EA3-4D6A-A6A3-6556878488D9.png

At the same time, he candidly acknowledged the limitations of current medical treatments. For some severe cases, recurrence and metastasis remain inevitable. “Even when tumors cannot be completely eliminated, we can still help patients achieve ‘living with cancer,’ prolong survival, and improve quality of life,” he said. He expressed hope to continue leveraging professional expertise and high-quality services to benefit more patients in the future.

Among the visitors, Dr. Tawatchai Chuwansombat, Senior Advisor of World Medical Center Hospital, and Ms. Pitchamon Pattamada, Vice Chairperson of Cosmi Co., Ltd., held particularly special roles. Not only are they experienced professionals in Thailand’s medical field, but they are also “witnesses” of Fuda’s care, having previously been family members of patients treated at the hospital. Their personal experiences gave them a deep appreciation of both Fuda’s medical technology and its humanistic care.

1ACD7927-253E-4C1F-A6DB-43ED5C913669.png

They stated that their visit, along with other Thai experts, was also driven by a sense of social responsibility. From the perspective of improving patients’ survival and quality of life, they hope to further strengthen China–Thailand friendship through exchange and cooperation, and jointly build high-quality medical services that offer better patient experiences.

During the meeting, both sides conducted in-depth discussions on teleconsultation services, integrated pre-, in-, and post-hospital care, and post-treatment follow-up and rehabilitation management. They expressed a shared expectation to establish a long-term and stable partnership, promoting complementary strengths and joint development in academic exchange, clinical technology, and patient services.

43C0EEAA-D7C1-483D-8032-2E633FFCCD8A.jpg

At the conclusion of the visit, both sides exchanged gifts as a token of friendship. The Thai delegation presented a sacred Thai totem—the Garuda—symbolizing their wish for Fuda to “soar high and achieve a bright future.” This meaningful gift stands as a testament to the strong and growing friendship between the two countries in the medical field.

Friendship transcends mountains and seas, and cooperation heals the future. This visit by the Thai medical delegation not only deepened mutual understanding and trust but also laid a solid foundation for long-term cooperation in cancer treatment between China and Thailand. In the future, Guangzhou Fuda Cancer Hospital will continue to uphold the principles of openness, sharing, and innovation, working hand in hand with medical institutions in Thailand and around the world to contribute greater wisdom and strength to global health.



Click to learn more patient stories:
>>> https://en.fudahospital.com/

You can contact us through the following channels:
☎️ TEL: +63 917 775 3426.
🌟 WhatsApp: +63 917 775 3426.
🌍 Website: https://en.fudahospital.com/

21/04/2026

APR.21.2026.
.
[Minimally Invasive Treatment] [Melanoma – Cryoablation]
>>>Hydrodissection-Assisted Cryoablation for 93-Year-Old Melanoma Patient> https://en.fudahospital.com/

You can contact us through the following channels:
☎️ TEL: +63 917 775 3426.
🌟 WhatsApp: +63 917 775 3426.
🌍 Website: https://en.fudahospital.com/

Address

Unit 2522, 25th Floor, Centuria Medical Makati Building
Makati
1210

Telephone

+639177753426

Website

Alerts

Be the first to know and let us send you an email when Fuda Cancer Hospital - Philippines posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Share